Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Yang

Showing results (151-160 of 162) with videos related to

Pageof 17
Sort By:
Retina (Philadelphia, Pa.)|February 2, 2017
REPEATABILITY AND LONGITUDINAL ASSESSMENT OF FOVEAL CONE STRUCTURE IN CNGB3-ASSOCIATED ACHROMATOPSIAChristopher S Langlo, Laura R Erker, Maria Parker, et al.
Investigative Ophthalmology & Visual Science|August 2, 2016
Residual Foveal Cone Structure in CNGB3-Associated AchromatopsiaChristopher S Langlo, Emily J Patterson, Brian P Higgins, et al.
Ophthalmic Genetics|July 5, 2021
Expanding the clinical phenotype in patients with disease causing variants associated with atypical Usher syndromeAustin D Igelman, Cristy Ku, Mariana Matioli da Palma, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 29, 2024
Loss-of-function variants in UBAP1L cause autosomal recessive retinal degenerationJi Hoon Han, Kim Rodenburg, Tamar Hayman, et al.
American Journal of Ophthalmology|March 6, 2022
Three-Year Safety Results of SAR422459 (EIAV-ABCA4) Gene Therapy in Patients With ABCA4-Associated Stargardt Disease: An Open-Label Dose-Escalation Phase I/IIa Clinical Trial, Cohorts 1-5Maria A Parker, Laura R Erker, Isabelle Audo, et al.
JAMA Ophthalmology|June 8, 2018
Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical TrialDavid G Birch, Paul S Bernstein, Alessandro Iannacone, et al.
Investigative Ophthalmology & Visual Science|June 29, 2021
Characterization of the Spectrum of Ophthalmic Changes in Patients With Alagille SyndromeMariana Matioli da Palma, Austin D Igelman, Cristy Ku, et al.
Translational Vision Science & Technology|August 25, 2020
Advancing Clinical Trials for Inherited Retinal Diseases: Recommendations from the Second Monaciano SymposiumDebra A Thompson, Alessandro Iannaccone, Robin R Ali, et al.
Translational Vision Science & Technology|August 27, 2025
Addressing Challenges in Developing Treatments for Inherited Retinal Diseases: Recommendations From the Third Monaciano SymposiumDebra A Thompson, K Thiran Jayasundera, Oleg Alekseev, et al.
NPJ Genomic Medicine|April 17, 2025
Variants in CFAP410 cause a range of retinal and skeletal phenotypesRyan E Schmidt, Amy E Pohodich, David Birch, et al.
Pageof 17

Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Retina (Philadelphia, Pa.)|February 2, 2017
REPEATABILITY AND LONGITUDINAL ASSESSMENT OF FOVEAL CONE STRUCTURE IN CNGB3-ASSOCIATED ACHROMATOPSIAChristopher S Langlo, Laura R Erker, Maria Parker, et al.
Investigative Ophthalmology & Visual Science|August 2, 2016
Residual Foveal Cone Structure in CNGB3-Associated AchromatopsiaChristopher S Langlo, Emily J Patterson, Brian P Higgins, et al.
Ophthalmic Genetics|July 5, 2021
Expanding the clinical phenotype in patients with disease causing variants associated with atypical Usher syndromeAustin D Igelman, Cristy Ku, Mariana Matioli da Palma, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 29, 2024
Loss-of-function variants in UBAP1L cause autosomal recessive retinal degenerationJi Hoon Han, Kim Rodenburg, Tamar Hayman, et al.
American Journal of Ophthalmology|March 6, 2022
Three-Year Safety Results of SAR422459 (EIAV-ABCA4) Gene Therapy in Patients With ABCA4-Associated Stargardt Disease: An Open-Label Dose-Escalation Phase I/IIa Clinical Trial, Cohorts 1-5Maria A Parker, Laura R Erker, Isabelle Audo, et al.
JAMA Ophthalmology|June 8, 2018
Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical TrialDavid G Birch, Paul S Bernstein, Alessandro Iannacone, et al.
Investigative Ophthalmology & Visual Science|June 29, 2021
Characterization of the Spectrum of Ophthalmic Changes in Patients With Alagille SyndromeMariana Matioli da Palma, Austin D Igelman, Cristy Ku, et al.
Translational Vision Science & Technology|August 25, 2020
Advancing Clinical Trials for Inherited Retinal Diseases: Recommendations from the Second Monaciano SymposiumDebra A Thompson, Alessandro Iannaccone, Robin R Ali, et al.
Translational Vision Science & Technology|August 27, 2025
Addressing Challenges in Developing Treatments for Inherited Retinal Diseases: Recommendations From the Third Monaciano SymposiumDebra A Thompson, K Thiran Jayasundera, Oleg Alekseev, et al.
NPJ Genomic Medicine|April 17, 2025
Variants in CFAP410 cause a range of retinal and skeletal phenotypesRyan E Schmidt, Amy E Pohodich, David Birch, et al.
Pageof 17